What is Mounjaro?
Mounjaro (tirzepatide) is a first-in-class dual GIP and GLP-1 receptor agonist developed by Eli Lilly. It is designed to improve blood sugar control in adults with type 2 diabetes and has shown significant potential in supporting weight loss as part of a comprehensive metabolic care plan. The drug has been approved by the FDA and Central Drugs Standard Control Organization (CDSCO).
Benefits
With rising rates of type 2 diabetes and obesity in India, Mounjaro represents a new standard in chronic care. Its dual-action mechanism helps regulate appetite, improve insulin sensitivity, and deliver real-world results backed by global clinical trials
Up to 22.5% weight loss in clinical trials among patients with obesity
Reduces HbA1c by up to 2.5 percentage points in adults with type 2 diabetes
Helps manage appetite and promote satiety for sustained lifestyle change
Improves insulin sensitivity and reduces insulin resistance
Our Services
01
Prescription Access Support
We coordinate with licensed medical professionals to ensure safe and compliant access to Mounjaro.
02
Onboarding & Training Kits
We provide patients with easy-to-follow training materials, injection technique guidance, and starter support.
03
Doorstep Delivery
Mounjaro is delivered securely and discreetly to your location — at no additional charge.
04
Lifestyle Integration Support
We guide patients with nutrition, activity, and behavioral tools to complement their clinical care plan.
How to Dose Mounjaro
2.5 Mg Once Weekly
Starting dose (for 4 weeks)
Month 1
5 Mg Once Weekly
For at-least 4 weeks
Month 2
We ensure every patient receives proper onboarding, detailed training toolkits, and personalized support to begin their Mounjaro journey with confidence. We also offer free doorstep delivery, making access seamless and hassle-free.
Frequently asked questions
- 01
- 02
- 03
- 04
- 05
- 06
- 07
- 08
Mounjaro in News
Has Mounjaro cracked the weight loss code? Experts find answers to obesity epidemic
Weight loss drug Mounjaro in India: Who needs it, how long should you have it and will weight come back?
Who should avoid taking viral drug Mounjaro? Expert explains
Weight loss drug Mounjaro launched in India: Know price, how it works, side-effects, and if it’s more effective than Ozempic
Mounjaro (tirzepatide) is currently only available in a vial form manufactured by Lilly. Mounjaro is not commercially available in any other form (e.g., powder for compounding). Products claiming to be compounded Mounjaro (tirzepatide) are not subject to CDSCO/FDA approval and may not have the same safety, quality and efficacy as CDSCO/FDA-approved drugs, and may expose patients to potentially serious health risks.
Source: Lilly